Cargando…

1871. Identifying Time Periods of High and Low Vancomycin Use

BACKGROUND: A national goal has been set to decrease inappropriate antibiotic use by 2020. To quantify decreases in use, consumption metrics and benchmarking strategies are implicit. However, while tracking and reporting antimicrobial use is widely recommended, these data do not address appropriaten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiajun, Mercuro, Nicholas, Davis, Susan, Yarnold, Paul R, Patel, Twisha S, Petty, Lindsay, Pais, Gwendolyn, Kaye, Keith, Scheetz, Marc H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253581/ http://dx.doi.org/10.1093/ofid/ofy210.1527

Ejemplares similares

2000. Utilization of a ‘Never Event’ Framework to Classify Antimicrobial Appropriateness
por: Liu, Jiajun, et al.
Publicado: (2019)

238. Novel Way to Evaluate Antibiotic Use Appropriateness: Moving Towards the “Never Event” Classification by Electronic Algorithm
por: Patel, Twisha S, et al.
Publicado: (2020)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury
por: Avedissian, Sean, et al.
Publicado: (2018)

Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
por: CHANG, Jack, et al.
Publicado: (2023)

1467. Clinical Significance of Microbiologic Treatment Failure Following Clinical Cure of Pneumonia
por: Albin, Owen, et al.
Publicado: (2018)

1394. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid (CSF) and Plasma Concentrations of Cefepime
por: Liu, Jiajun, et al.
Publicado: (2018)

1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
por: Pais, Gwendolyn M, et al.
Publicado: (2019)

2222. Impact of Empiric Aminoglycoside Usage on Outcomes in Bacterial Pneumonia
por: Albin, Owen, et al.
Publicado: (2019)

216. Step-down Therapy With Oral Fluoroquinolones vs. Oral β-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

1569. A Translational Model to Assess the Impact of Polymyxin B Dose Fractionation on Kidney Injury
por: Liu, Jiajun, et al.
Publicado: (2019)

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

869. Evaluation of Broad-Spectrum Antibiotic De-Escalation in Patients with Health-Care Associated Pneumonia (HCAP) and No Microbiological Diagnosis
por: Patel, Twisha S, et al.
Publicado: (2018)

1329. Vancomycin Therapeutic Drug Monitoring: How to hit the Curve
por: Vala, Michael, et al.
Publicado: (2020)

In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes
por: Papp, Nicole, et al.
Publicado: (2022)

1821. Understanding the Components and Calculation of the SAAR, Illustrative Data
por: Avedissian, Sean, et al.
Publicado: (2018)

1071. Impact of Standard vs. Prolonged Courses of Antibiotics for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia (SAB) in Patients With Hematologic Malignancies
por: Cheung, Edna, et al.
Publicado: (2018)

1035. Implementation of an Antimicrobial Stewardship Program-Led, Multifactorial Pneumonia Diagnosis and Treatment Bundle
por: Cua, Jefferson L, et al.
Publicado: (2019)

Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study
por: Liu, Jiajun, et al.
Publicado: (2020)

1391. Vancomycin Area Under the Curve (AUC) to Predict Nephrotoxicity: A Systematic Review and Meta-Analysis of Observational Studies
por: Aljefri, Doaa, et al.
Publicado: (2018)

223. Predicting Mortality Among Immunocompromised Patients Who Present With Bloodstream Infection
por: Henig, Oryan, et al.
Publicado: (2019)

1056. Evaluation of Clinical Outcomes Following Implementation of Real-Time Stewardship Team Interventions for Multi-Drug-Resistant Organisms
por: Xhemali, Xhilda, et al.
Publicado: (2019)

1083. Risk Factors Associated with Treatment of Asymptomatic Bacteriuria in the Emergency Department: A Multi-Hospital Cohort Study
por: Petty, Lindsay A, et al.
Publicado: (2019)

1600. Susceptibility of β-Lactam-Resistant Pseudomonas aeruginosa to Other β-Lactams: Is There Truly a Lack of Cross-Resistance?
por: Patel, Twisha S, et al.
Publicado: (2019)

2406. “Real-world” Treatment of Multidrug-Resistant (MDR) or Extensively Drug-Resistant (XDR) P. aeruginosa Infections With Ceftolozane/Tazobactam (C/T) vs. a Polymyxin or Aminoglycoside (Poly/AG)-based Regimen: A Multicenter Comparative Effectiveness Study
por: Pogue, Jason M, et al.
Publicado: (2018)

1871. Lessons Learned from IGRA Test Practices in a Tertiary Hospital
por: Daas, Farah, et al.
Publicado: (2023)

A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
por: Boyd, Anthony M, et al.
Publicado: (2017)

Vancomycin-Resistant Enterococcus Acquisition in a Tertiary Care Hospital: Testing the Roles of Antibiotic Use, Proton Pump Inhibitor Use, and Colonization Pressure
por: Chanderraj, Rishi, et al.
Publicado: (2019)

1019. Treatment Outcomes for Enterococcus faecium Bacteremia in Solid-Organ Transplant Patients: Implications for Daptomycin
por: Mercuro, Nicholas J, et al.
Publicado: (2018)

Blood Biomarkers and Metabolomic Profiling for the Early Diagnosis of Vancomycin-Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis of Experimental Studies
por: Laou, Eleni, et al.
Publicado: (2022)

Cases Treated in 1871
por: Huq, Mahomed Sudrool
Publicado: (1872)

The Secunderabad Cholera of 1871
Publicado: (1871)

Yearbook of Pharmacy for 1871
Publicado: (1872)

The Medical Directory, 1871
Publicado: (1871)

1981. Implementation of an Antifungal Stewardship Bundle Focused on Candidemia in an Indian Hospital
por: Moni, Merlin, et al.
Publicado: (2019)

521. Comparative In Vitro Activity of Meropenem/Vaborbactam and Meropenem Against a Collection of Real-World Clinical Isolates of Pseudomonas aeruginosa
por: Patel, Twisha S, et al.
Publicado: (2019)

522. In Vitro Antimicrobial Activity of Ceftazidime/Avibactam Compared with Ceftolozane/Tazobactam Against Real-world Clinical Isolates of Pseudomonas aeruginosa at a Large Academic Tertiary Care Hospital
por: Patel, Twisha S, et al.
Publicado: (2019)

Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
por: Joshi, Medha D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o6m27ks9mo4ka3fh88oo39h1c8